Description

1,3-Benzenedicarboxamide, 5-[Acetyl[2-(2,3-Dihydroxypropoxy)-3-Hydroxypropyl]Amino]-N1,N3-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo- is a sophisticated, non-ionic iodinated compound designed for advanced diagnostic and research applications. Its molecular architecture provides excellent water solubility and low osmolality, making it a critical component for high-performance contrast media. This compound is essential for manufacturers and research institutions developing next-generation X-ray and computed tomography (CT) imaging agents. Its precise synthesis and high purity are paramount for ensuring patient safety and diagnostic accuracy.

Application

• X-ray and CT Contrast Media: Primary active pharmaceutical ingredient (API) or key intermediate in the formulation of non-ionic, low-osmolar iodinated contrast agents.
• Pharmaceutical Intermediates: Serves as a crucial building block in the multi-step synthesis of advanced diagnostic pharmaceuticals.
• Biomedical Research: Used in research laboratories for studying vascular permeability, renal function, and developing novel imaging probes.
• Diagnostic Agent Development: A foundational material for R&D teams creating new formulations with improved safety profiles and imaging characteristics.
• Radiopharmaceutical Precursors: Potential intermediate for compounds used in specialized imaging techniques, given its iodinated aromatic core.

Basic Information

Item	Detail
Product Name	1,3-Benzenedicarboxamide, 5-[Acetyl[2-(2,3-Dihydroxypropoxy)-3-Hydroxypropyl]Amino]-N1,N3-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo-
CAS No.	2724765-15-3
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	5-[Acetyl[2-(2,3-Dihydroxypropoxy)-3-Hydroxypropyl]Amino]-N1,N3-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodoisophthalamide; Non-ionic Triiodinated Isophthalamide Derivative; Iodinated Contrast Media Intermediate; CT Contrast Agent Intermediate; Advanced Iodinated Aromatic Amide; Diagnostic Imaging Compound; Research Grade Iodinated Benzenedicarboxamide
EINECS	Contact for details

Quality Control

Every batch of this high-value intermediate is produced under strict quality management systems, adhering to current industry best practices for pharmaceutical intermediates. Our quality control protocol includes comprehensive analytical testing to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting key parameters such as assay, related substances, and residual solvents. We support compliance with ICH guidelines and can tailor specifications to meet specific project or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH limits
Heavy Metals	< 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.